INNOVAX®-ILT-IBD, the first vaccine to prevent ILT, IBD, and MD in a single dose, now available in the EU, will be highlighted in a symposium Multiple studies continue to support the benefit of INNOVAX®-ND-IBD, the first vaccine against classic and variant IBD, ND and MD in a single dose RAHWAY, N.J., August 29, 2023 – […]
Gp40 antigen vaccine elicits immune response against Cryptosporidium parvum in pregnant cows to protect their newborn calves through antibodies in colostrum Combined data represent first efficacious C. parvum maternal vaccine worldwide for any species RAHWAY, N.J., August 24, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced […]
Biomass estimation unit provides key information about average weight, distribution, and growth trends RAHWAY, N.J., August 21, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the launch of FALCON® Biomass, a powerful, always-on biomass estimation unit that provides key information about average weight, distribution, and […]
First EU-licensed poultry vaccine to prevent development of ILT, IBD and MD without the risk of reversion to virulence of ILT Rahway, N.J., June 12, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today that the European Commission has approved INNOVAX®-ILT-IBD, a dual-construct HVT vaccine that provides […]
Multiple studies demonstrate the benefit of needle-free vaccination for the prevention and management of Lawsonia intracellularis Additional novel research includes reproductive health, preventive farm care and herd health management MADISON, N.J., May 24, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the presentation of 19 […]
Novel injectable suspension delivers ongoing efficacy against fleas and ticks for dogs six months and older in a single dose MADISON, N.J., May 1, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the Australian Pesticides and Veterinary Medicines Authority (APVMA) has approved a novel injectable […]
First vaccine for bovine coronavirus (BCoV), to protect newborn calves against respiratory disease MADISON, NJ, APRIL 4, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the European Commission granted marketing authorization for BOVILIS® Nasalgen®-C, a bovine coronavirus (BCoV) vaccine for cattle. The intranasal, live vaccine can […]
Virtual event featuring 12 global experts offered free to veterinary professionals MADISON, N.J., March 16, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the company will host a virtual continuing education symposium featuring 12 experts from around the world. This event, sponsored by NOBIVAC® will be […]
Winning veterinary student sets out to examine canine tick-borne diseases in Nepal MADISON N.J., February 23, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the inaugural recipient of the World Small Animal Veterinary Association (WSAVA) Michael J. Day Scholarship, Somnath Aryal. Aryal, a Nepalese veterinary student […]
Dutch Minister Micky Adriaansens attends official facility opening Facility capacity to meet increased global customer demand for our innovative vaccines BOXMEER, the Netherlands, Jan. 23, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the opening of a state-of-the-art manufacturing facility in Boxmeer, the Netherlands, for […]